What are the treatment options for metastatic Stomach Cancer

Treatment Options for Metastatic Stomach Cancer

When stomach cancer has spread to distant sites (metastatic disease), the treatment approach shifts to focus on controlling the cancer and managing symptoms. Let me walk you through the main options your oncology team might discuss.

How Doctors Think About Metastatic Stomach Cancer

According to NCCN Guidelines for Gastric Cancer, the treatment strategy depends on several key factors:

• Whether the cancer can be surgically removed (resectable vs. unresectable)
• Your overall health and ability to tolerate treatment
• Where the cancer has spread (liver, lungs, peritoneum/abdominal lining, etc.)
• Specific biomarkers like MSI-H/dMMR status (which affects immunotherapy eligibility)

Main Treatment Approaches

1. Systemic Therapy (Chemotherapy/Immunotherapy)

This is typically the foundation of treatment for metastatic stomach cancer. According to NCCN Guidelines, systemic therapy is recommended as a primary approach.

Standard chemotherapy options generally include:

• Fluoropyrimidine-based regimens (5-FU or capecitabine)
• Combination chemotherapy approaches
• These work by targeting cancer cells throughout the body

Immunotherapy consideration: If your tumor has MSI-H (microsatellite instability-high) or dMMR (mismatch repair deficient) status, NCCN Guidelines specifically recommend considering immune checkpoint inhibitors (ICIs) as part of perioperative or systemic therapy. These drugs help your immune system recognize and attack cancer cells.

2. Surgery (In Selected Cases)

This might seem counterintuitive for metastatic disease, but NCCN Guidelines indicate surgery can still play a role:

• Primary tumor removal may be considered if you have symptoms (bleeding, obstruction, perforation) or if it would improve quality of life
• Metastasectomy (removal of specific metastatic sites) might be discussed in select cases, particularly if there are limited metastases in one area
• Surgery is typically combined with systemic therapy, not used alone

3. Palliative Management

This is an important part of care at any stage and focuses on:

• Managing pain and other symptoms
• Maintaining quality of life
• Addressing complications like bleeding or obstruction
• Nutritional support (sometimes including feeding tubes)

Special Consideration: Peritoneal Metastases

If your cancer has spread to the peritoneum (the lining of the abdominal cavity), NCCN Guidelines recommend systemic therapy for a minimum of 3 months as the primary approach, often combined with multidisciplinary consultation.

---

Questions to Ask Your Oncology Team

Since YOUR specific situation requires your doctor's evaluation, here are important questions to guide your conversation:

1. "What is the extent of my metastatic disease, and where has the cancer spread?" (This determines what's surgically possible)

2. "Has my tumor been tested for MSI-H/dMMR status?" (This directly impacts whether immunotherapy is an option)

3. "What systemic therapy regimen do you recommend for me, and what are the expected side effects?"

4. "Is there any role for surgery in my case—either to remove my primary tumor or specific metastases?"

5. "What is the goal of treatment—to shrink the cancer, control symptoms, or extend survival—and what timeline should I expect?"

6. "Are there clinical trials available that might be appropriate for my specific situation?"

---

Important Context

According to NCCN Guidelines, your oncologist will determine the most appropriate approach based on:

• Your complete staging workup (CT, PET scans, endoscopy findings)
• Pathology review and biomarker testing results
• Your performance status (ability to tolerate treatment)
• Your personal preferences and goals of care

The combination of systemic therapy with potential surgical intervention, when appropriate, offers the best outcomes for many patients with metastatic stomach cancer.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.